UNIVERSITY COLLEGE LONDON
π¬π§United Kingdom
- Country
- π¬π§United Kingdom
- Ownership
- Private
- Established
- 1826-02-11
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ucl.ac.uk
[18F]FPIA PET/CT Imaging in Patients With Solid Tumours
Phase 2
Recruiting
- Conditions
- CancerTumor, Solid
- Interventions
- Drug: [18F]Fluoropivalate ([18F]Fluoro-2,2-Dimethylpropionic Acid)Procedure: PET/CT
- First Posted Date
- 2021-01-22
- Last Posted Date
- 2023-10-03
- Lead Sponsor
- University College, London
- Target Recruit Count
- 21
- Registration Number
- NCT04717674
- Locations
- π¬π§
The Royal Marsden NHS Foundation Trust, London, United Kingdom
π¬π§Guy's & St. Thomas' NHS Foundation Trust, London, United Kingdom
π¬π§Imperial College Healthcare NHS Trust, London, United Kingdom
Different Dialysis Modalities and Diet on Gastrointestinal Biome and Azotaemic Toxins
Recruiting
- Conditions
- Kidney Failure
- First Posted Date
- 2021-01-19
- Last Posted Date
- 2021-01-19
- Lead Sponsor
- University College, London
- Target Recruit Count
- 100
- Registration Number
- NCT04714853
- Locations
- π¬π§
Royal Free Hospital, London, United Kingdom
Group CST Using Zoom: A Proof of Concept Study
Not Applicable
- Conditions
- Dementia
- Interventions
- Other: Online Cognitive Stimulation Therapy
- First Posted Date
- 2021-01-05
- Last Posted Date
- 2021-01-05
- Lead Sponsor
- University College, London
- Target Recruit Count
- 50
- Registration Number
- NCT04695743
- Locations
- π¬π§
University College London, London, United Kingdom
Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
Phase 3
Recruiting
- Conditions
- Hodgkin Lymphoma
- Interventions
- Radiation: Involved site radiotherapyDrug: Haematopoietic growth factor
- First Posted Date
- 2020-12-28
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- University College, London
- Target Recruit Count
- 1042
- Registration Number
- NCT04685616
- Locations
- πΊπΈ
Stanford University - (Stanford Cancer Institute), Stanford, California, United States
πΊπΈUniversity of Miami School of Medicine, Miami, Florida, United States
πΊπΈMemorial Sloan Kettering Cancer Center, New York, New York, United States
CiproPAL (Ciprofloxacin Prophylaxis in Acute Leukaemia)
Not Applicable
Recruiting
- Conditions
- Acute Lymphoblastic Leukaemia - Category
- Interventions
- First Posted Date
- 2020-12-22
- Last Posted Date
- 2024-03-08
- Lead Sponsor
- University College, London
- Target Recruit Count
- 1052
- Registration Number
- NCT04678869
- Locations
- π¬π§
Addenbrookes Hospital, Cambridge, United Kingdom
π¬π§Nottingham Children's Hospital, Nottingham, United Kingdom
π¬π§Bristol Royal Hospital for Children, Bristol, United Kingdom
Transcranial Direct Current Stimulation in Post-stroke Fatigue
Not Applicable
Completed
- Conditions
- FatigueStroke
- Interventions
- Device: Anodal tDCSDevice: sham tDCS
- First Posted Date
- 2020-11-18
- Last Posted Date
- 2020-11-18
- Lead Sponsor
- University College, London
- Target Recruit Count
- 33
- Registration Number
- NCT04634864
- Locations
- π¬π§
33 Queen Square, Institute of Neurology, UCL, London, United Kingdom
Mechanisms of Excess Risk in Aortic Stenosis
Recruiting
- Conditions
- Aortic StenosisNon-Sustained VTHeart Failure
- Interventions
- Diagnostic Test: Cardiac MRI scanDiagnostic Test: Serum biomarkers (High sensitivity troponin, NT-proBNPProcedure: Implantable Loop RecorderDiagnostic Test: 6 minute walk testDiagnostic Test: Echocardiogram
- First Posted Date
- 2020-11-13
- Last Posted Date
- 2021-04-30
- Lead Sponsor
- University College, London
- Target Recruit Count
- 192
- Registration Number
- NCT04627987
- Locations
- π¬π§
Barts Heart Centre, London, United Kingdom
Use of Frequency Compression in Severe-profound Hearing Loss Adults
Not Applicable
Completed
- Conditions
- Frequency CompressionSevere-profound Hearing Impairment
- First Posted Date
- 2020-11-10
- Last Posted Date
- 2020-11-10
- Lead Sponsor
- University College, London
- Target Recruit Count
- 27
- Registration Number
- NCT04623112
Study of Plasma Exchange in Severe COVID-19
- First Posted Date
- 2020-11-10
- Last Posted Date
- 2024-06-07
- Lead Sponsor
- University College, London
- Target Recruit Count
- 23
- Registration Number
- NCT04623255
- Locations
- π¬π§
University College London Hospital, London, United Kingdom
Lentiviral Gene Therapy for Epilepsy
Phase 1
Not yet recruiting
- Conditions
- Drug Resistant Epilepsy
- Interventions
- Genetic: lentiviral gene therapy
- First Posted Date
- 2020-10-26
- Last Posted Date
- 2023-05-15
- Lead Sponsor
- University College, London
- Target Recruit Count
- 10
- Registration Number
- NCT04601974
Β© Copyright 2025. All Rights Reserved by MedPath